Parkinson's disease

A survey in Germany found more than eight percent of patients with Parkinson's disease are using cannabis products and more than half experienced beneficial clinical effects

The development of the genetically modified tomato has implications for developing nations where access to pharmaceutical drugs is restricted

A research team is examining the potential link between COVID-19 and increased risk of Parkinson's disease, as well as measures to get ahead of the curve

MSU's Wen Li and Erin Purcell are leading the effort to use innovative diamond devices to monitor the brain's biochemistry for early warning signs of disease

The drug, HU-308, lessens involuntary movements called dyskinesias, a side effect from years of treatment for Parkinson's disease

Rutgers innovation may help guide treatment of Alzheimer's, Parkinson's diseases

Study reveals crucial role of alpha-synuclein protein in DNA repair

Experiments in mice show transmission of nerve-killing protein from the gut into the brain

Researchers believe an enzyme targeted to the neuronal mitochondria may be responsible for converting compounds from alcohol, tobacco, and certain foods into chemicals that trigger or advance the disease

A novel gene therapy approach blocks the accumulation of α-synuclein in the brain, preventing the development of Parkinson's disease